These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34399036)

  • 1. Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic models.
    Truong VT; Baverel PG; Lythe GD; Vicini P; Yates JWT; Dubois VFS
    CPT Pharmacometrics Syst Pharmacol; 2022 Feb; 11(2):133-148. PubMed ID: 34399036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ordinary differential equations with applications in molecular biology.
    Ilea M; Turnea M; Rotariu M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):347-52. PubMed ID: 23077920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ordinary differential equation models for ethanol pharmacokinetic based on anatomy and physiology.
    Han JJ; Plawecki MH; Doerschuk PC; Ramchandani VA; O'Connor S
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():5033-6. PubMed ID: 17945874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.
    Graf JF; Scholz BJ; Zavodszky MI
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):37-54. PubMed ID: 22161221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling cancer progression: an integrated workflow extending data-driven kinetic models to bio-mechanical PDE models.
    Mohammad Mirzaei N; Shahriyari L
    Phys Biol; 2024 Feb; 21(2):. PubMed ID: 38330444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Systems Pharmacology and Physiologically-Based Pharmacokinetic Modeling With mrgsolve: A Hands-On Tutorial.
    Elmokadem A; Riggs MM; Baron KT
    CPT Pharmacometrics Syst Pharmacol; 2019 Dec; 8(12):883-893. PubMed ID: 31652028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
    Gieschke R; Steimer JL
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical modeling and computational prediction of cancer drug resistance.
    Sun X; Hu B
    Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulating cancer growth with multiscale agent-based modeling.
    Wang Z; Butner JD; Kerketta R; Cristini V; Deisboeck TS
    Semin Cancer Biol; 2015 Feb; 30():70-8. PubMed ID: 24793698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal Therapy Scheduling Based on a Pair of Collaterally Sensitive Drugs.
    Yoon N; Vander Velde R; Marusyk A; Scott JG
    Bull Math Biol; 2018 Jul; 80(7):1776-1809. PubMed ID: 29736596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary Flow Modeling by Hybrid Automata Alternating Continuous Reaction and Discrete Transit for Pharmacokinetics.
    Koyama S
    Drug Metab Dispos; 2021 Jul; 49(7):521-529. PubMed ID: 33941544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient algorithms for ordinary differential equation model identification of biological systems.
    Gennemark P; Wedelin D
    IET Syst Biol; 2007 Mar; 1(2):120-9. PubMed ID: 17441553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer Immunotherapy.
    Ribba B; Boetsch C; Nayak T; Grimm HP; Charo J; Evers S; Klein C; Tessier J; Charoin JE; Phipps A; Pisa P; Teichgräber V
    Clin Cancer Res; 2018 Jul; 24(14):3325-3333. PubMed ID: 29463551
    [No Abstract]   [Full Text] [Related]  

  • 14. Learning differential equation models from stochastic agent-based model simulations.
    Nardini JT; Baker RE; Simpson MJ; Flores KB
    J R Soc Interface; 2021 Mar; 18(176):20200987. PubMed ID: 33726540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumping in pharmacokinetics.
    Brochot C; Tóth J; Bois FY
    J Pharmacokinet Pharmacodyn; 2005 Dec; 32(5-6):719-36. PubMed ID: 16341473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Pharmacometrics of 5-Fluorouracil to Personalized Medicine: A Tool for Predicting Pharmacokinetic-Pharmacodynamic/Toxicodynamic Responses.
    Kobuchi S; Ito Y
    Anticancer Res; 2020 Dec; 40(12):6585-6597. PubMed ID: 33288553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic-pharmacodynamic modelling in oncology: a tool for predicting clinical response.
    Bender BC; Schindler E; Friberg LE
    Br J Clin Pharmacol; 2015 Jan; 79(1):56-71. PubMed ID: 24134068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation of Continuum Models from An Agent-based Cancer Model: Optimization and Sensitivity Analysis.
    Voulgarelis D; Velayudhan A; Smith F
    Curr Pharm Biotechnol; 2017; 18(15):1249-1263. PubMed ID: 29595105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-linear mixed-effects pharmacokinetic/pharmacodynamic modelling in NLME using differential equations.
    Tornøe CW; Agersø H; Jonsson EN; Madsen H; Nielsen HA
    Comput Methods Programs Biomed; 2004 Oct; 76(1):31-40. PubMed ID: 15313540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to In Silico Modeling to Study ROS Dynamics.
    Schleicher J
    Methods Mol Biol; 2021; 2202():1-32. PubMed ID: 32857342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.